Effects of resveratrol on mood and cognition in patients with type 2 diabetes

Phase 3

• Conditions: Diabetes mellitus.; Non-insulin-dependent diabetes mellitus

• Registration Number: IRCT201411112394N14
• Lead Sponsor: Vice chancellor for research, Iran University of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

diagnosis of type 2 Diabetes for at least 2 years; willing to participate; a minimum score of 10 in Beck Depression Inventory; age between 45 to 70 years old. Exclusion criteria: Significant diseases including cardiovascular, renal and liver diseases, or cancer; pregnancy; lactation; consumption of antidepressant agents within the past 8 weeks; insulin use; consumption of nutritional supplements within the past 8 weeks.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mood. Timepoint: At baseline and after weeks 4 and 8. Method of measurement: Beck Depression Inventory.;Cognitive performance. Timepoint: At baseline and after weeks 4 and 8. Method of measurement: Questionnaire.;Serum BDNF(brain-derived neurotrophic factor ). Timepoint: At baseline and after 8 weeks. Method of measurement: ELISA.

Secondary Outcome Measures

Name	Time	Method
HbA1c. Timepoint: At baseline and after 8 weeks. Method of measurement: Biochemical Assessment.;Fasting Blood Sugar. Timepoint: At the begining and end(week 8) of intervention. Method of measurement: Biochemical measurements.